In the present study, we found that simvastatin markedly inhibited cell invasion in human breast cancer cell lines via down-regulating the expression of PTTG1, a key oncogenic gene involved in cancer invasion and metastasis (Grizzi et al., 2013). The gene discussed is PTTG1; the disease is breast carcinoma.